Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~Patients who have:~* Been admitted to the medical unit on 7 West at St. Luke's Hospital (Duluth, MN)~* Been prescribed a systemic antibiotic of any kind (administered by oral or parenteral route), but have not yet started the regimen~* Consented to be randomized and take part in the study and are adults greater than 19 years of age~Exclusion Criteria:~Patients who are/have:~* Tube feeding~* Undergoing dialysis and other renal treatment~* An existing C. difficile infection~* A recent history of C. difficile infection (within the last 3 months)~* A recent history of antibiotic use (within the last 3 months)~* Inflammatory bowel disease, Crohn's disease, or other chronic gastrointestinal syndrome~* A history of acquired of genetic immunodeficiencies; active, acute or chronic serious infections (i.e., viral hepatitis, HIV/AIDS), or autoimmune disorders~* Undergoing gastrointestinal surgery, radiation, or cytotoxic chemotherapy~* Allergy to milk protein

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group A (Type: NO_INTERVENTION): Will receive prescribed antibiotics and will not receive kefir. Patients in this arm will be asked to record daily symptoms of diarrhea for up to 30 days post-discharge.
- Group B (Type: ACTIVE_COMPARATOR): Will receive prescribed antibiotics and will receive kefir only during hospital stay. Patients in this arm will be asked to record daily symptoms of diarrhea for up to 30 days post-discharge.
- Group C (Type: ACTIVE_COMPARATOR): Will receive prescribed antibiotics and will receive kefir during hospital stay and for the duration of the prescribed antibiotic regimen for up to a total of 30 days . Patients in this arm will be asked to record daily symptoms of diarrhea for up to 30 days post-discharge.

Based on this trial design, predict the completion outcome and termination type (if applicable).